Showing results (121-130 of 313) with videos related to

Sort By:
Pageof 32
Diabetes, Obesity & Metabolism|September 28, 2018
Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar StudyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
Endocrine Research|March 29, 2011
β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging RatsGiovanna Muscogiuri, Amrita Kamat, Bogdan Balas, et al.
Metabolism: Clinical and Experimental|September 28, 2011
Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic modelsAndrea Tura, Giovanni Pacini, Alexandra Kautzky-Willer, et al.
The FEBS Journal|December 18, 2016
Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytesChristopher E Shannon, Giuseppe Daniele, Cynthia Galindo, et al.
Diabetes Care|November 15, 2007
Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic rangeRucha Jani, Marjorie Molina, Masafumi Matsuda, et al.
Diabetes Care|August 21, 2014
Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adultsSteven K Malin, Sangeeta R Kashyap, Jeff Hammel, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 15, 2005
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of trainingApiradee Sriwijitkamol, John L Ivy, Christine Christ-Roberts, et al.
Diabetes Care|July 17, 2020
Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysisNitchakarn Laichuthai, Muhammad Abdul-Ghani, Mikhail Kosiborod, et al.
Diabetes Care|May 27, 2026
Renal Lipotoxicity: Mechanisms and Therapeutic PerspectivesHussein Zaitoon, Eugene Feigin, Muhammad Abdul-Ghani, et al.
Pageof 32